With our cardiovascular training methods, Noble Life Sciences brings comprehensive expertise to the development of these tests. Our medical device division provides surgical expertise and supports utilizing state of the art equipment to better our understanding of cardiovascular disease and injury.
Noble’s Efficacy Modeling capabilities range from oncology to infectious diseases, making us a valuable asset in the therapeutic world. In addition to our standardized model offerings, we excel in new model development and characterization.
We deliver data that enables more confident decisions.
Learn more about our Cell & Gene Therapy Services
Resources & White Papers
PASSIONATE ABOUT COLLABORATING FOR A CURE
Introduction The study aims to establish an orthotopic liver cancer model in nude mice and evaluate the anti-tumor efficacy of Sorafenib. Liver cancer is a leading cause of...
Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). The model’s popularity derives from its ease of use with small and expensive animals, short-duration experiments with reproducible infections, and simple end-points.
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays
The in vivo animal tumor models possessing fully functional immunity are essential for preclinical research of new immunotherapeutic medicine. Syngeneic tumor models are...